| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(70)91328-0 |
| P8608 | Fatcat ID | release_inwqqyw7djdejeundypnroy2da |
| P698 | PubMed publication ID | 4194360 |
| P2093 | author name string | I M Roitt | |
| M H Williams | |||
| J Brostoff | |||
| P2860 | cites work | Response to autologous immunoglobulin G in patients with rheumatoid arthritis | Q33580021 |
| In vitro synthesis of immunoglobulin by rheumatoid synovial membrane | Q34272996 | ||
| Cell-mediated (delayed) hypersensitivity in patients with summer hay-fever | Q40936476 | ||
| The chronicity of inflammation and its significance in rheumatoid arthritis | Q42586460 | ||
| Ultrastructure of synovial membrane in rheumatoid arthritis | Q42586937 | ||
| Cell Migration Inhibition Factor released by Antigen from Human Peripheral Lymphocytes | Q44109441 | ||
| Elevated IgG antiglobulins in patients with seronegative rheumatoid arthritis. | Q54018737 | ||
| Intracytoplasmic inclusions of immunoglobulins in rheumatoid arthritis and other diseases. | Q54497203 | ||
| Antigenicity of Mycoplasma Membranes | Q59037380 | ||
| OSMOTIC LYSIS OF MYCOPLASMA | Q76715268 | ||
| CHOLESTEROL AND CHOLESTEROL ESTERS IN MYCOPLASMA | Q78321340 | ||
| The attachment of proteins to aldehyde-tanned cells | Q79060266 | ||
| P433 | issue | 7667 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| Mycoplasma fermentans | Q3869003 | ||
| P304 | page(s) | 277-280 | |
| P577 | publication date | 1970-08-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Possible role of Mycoplasma fermentans in pathogenesis of rheumatoid arthritis | |
| P478 | volume | 2 |
| Q39529775 | A 4.1-kilodalton polypeptide in the cultural supernatant of Mycoplasma fermentans is one of the substances responsible for induction of interleukin-6 production by human gingival fibroblasts |
| Q41254722 | A micro-method for peripheral leucocyte migration in tuberculin sensitivity |
| Q34548354 | A role for intestinal mycoplasmas in the aetiology of Crohn's disease? |
| Q46718758 | A simplified macrophage migration inhibition test to measure T-cell derived immunity in man |
| Q21199578 | Animal model of Mycoplasma fermentans respiratory infection |
| Q70001020 | Cell-mediated immunity to synovial antigens in rheumatoid arthritis |
| Q34727431 | Choline-containing lipids in mycoplasmas |
| Q43516741 | Deficient lymphoid cell-mediated, PHA-induced cytotoxicity in rheumatoid arthritis patients |
| Q71154525 | Delayed Type Hypersensitivity in Hamsters Infected withMycoplasma pneumoniaeas Revealed by Macrophage Migration Inhibition Test |
| Q93700362 | Delayed hypersensitivity in mycoplasma pneumoniae infections |
| Q43909661 | Disodium cromoglycate in allergic rhinitis |
| Q34002676 | Effect of MALP-2, a lipopeptide from Mycoplasma fermentans, on bone resorption in vitro. |
| Q39085635 | Effects of Ureaplasma urealyticum lipid-associated membrane proteins on rheumatoid arthritis synovial fibroblasts |
| Q43001892 | Effects of salicylates on blood changes in mycoplasma arthritis in rats |
| Q41316849 | Electron and light microscopical observations and serological findings in rheumatoid arthritis |
| Q24795225 | Experimental arthritis induced by a clinical Mycoplasma fermentans isolate |
| Q33666775 | Genotypic and phenotypic analysis of Mycoplasma fermentans strains isolated from different host tissues |
| Q33665507 | Genotypic characterization of seven strains of Mycoplasma fermentans isolated from synovial fluids of patients with arthritis |
| Q34827996 | Human diseases associated with mycoplasms. With an appendix on simple culture techniques |
| Q33964835 | Identification of Mycoplasma fermentans in synovial fluid samples from arthritis patients with inflammatory disease |
| Q39515684 | Identification of Ureaplasma urealyticum (T-strain Mycoplasma) in patient with polyarthritis |
| Q41402570 | Identification of phosphocholine-containing glycoglycerolipids purified from Mycoplasma fermentans-infected human helper T-cell culture as components of M. fermentans |
| Q33567811 | Immunological reactivity to Mycoplasma fermentans in patients with rheumatoid arthritis. Preliminary communication |
| Q41067808 | Incidence of Hepatitis Associated Antigen HAA and Homologous Antibody in Patients with Rheumatoid Arthritis |
| Q27486430 | Infectious diseases: annual review of significant publications |
| Q48765700 | Intracerebral administration of Mycoplasma fermentans produces sickness behavior: role of prostaglandins. |
| Q36988763 | Involvement of interleukin-1 (IL-1), IL-6, IL-2, and IL-4 in generation of cytolytic T cells from thymocytes stimulated by a Mycoplasma fermentans-derived product |
| Q93722095 | Killing of mycoplasmas by the antibodies to foreign antigens acquired by the organisms from the growth medium |
| Q54085068 | Leucocyte migration inhibition with aggregated gamma globulin in patients with rheumatoid arthritis |
| Q33568791 | Leucocyte migration-inhibition in systemic lupus erythematosus |
| Q43491996 | Leucocyte-migration inhibition in rheumatoid arthritis |
| Q93701717 | Leucocyte-migration inhibition induced by IgG in rheumatoid arthritis |
| Q93701714 | Lymphocyte reactivity against lymphoma cells in rheumatoid arthritis |
| Q30938673 | Monoclonal antibody against Mycoplasma fermentans-specific aminoglycoglycerolipid |
| Q37224105 | Mycoplasma fermentans, but not M penetrans, detected by PCR assays in synovium from patients with rheumatoid arthritis and other rheumatic disorders |
| Q36980940 | Mycoplasma fermentans-derived high-molecular-weight material induces interleukin-6 release in cultures of murine macrophages and human monocytes |
| Q40669352 | Mycoplasma fermentans-derived lipid inhibits class II major histocompatibility complex expression without mediation by interleukin-6, interleukin-10, tumor necrosis factor, transforming growth factor-beta, type I interferon, prostaglandins or nitric |
| Q42663115 | Mycoplasma infection of cell lines can simulate the expression of Fc receptors by binding of the carbohydrate moiety of antibodies |
| Q43440414 | Mycoplasma pulmonis arthritis in congenitally athymic (nude) mice. Clinical and biological features |
| Q34104408 | Mycoplasma-Associated Immunosuppression: Effect on Hemagglutinin Response to Common Antigens in Rabbits |
| Q40725783 | Mycoplasmal lipoproteins induce toll-like receptor 2- and caspases-mediated cell death in lymphocytes and monocytes |
| Q33568589 | Mycoplasmas and bacteria in synovial fluid from patients with arthritis |
| Q41323164 | Mycoplasmas and rheumatoid arthritis |
| Q33566191 | Mycoplasmas and ureaplasmas in patients with hypogammaglobulinaemia and their role in arthritis: microbiological observations over twenty years |
| Q37094314 | Myositis in father and daughter |
| Q36632868 | Oral mycoplasmas in Sjogren's syndrome |
| Q35599873 | PCR methods in clinical investigations of human ureaplasmas: a minireview |
| Q33567874 | Palindromic rheumatism. Clinical and immunological studies |
| Q35864704 | Peroxidase arthritis. 3. Sequential changes in cellular composition of the developing inflammatory infiltrate |
| Q36078227 | Peroxidase arthritis. I. An immunologically mediated inflammatory response with ultrastructural cytochemical localization of antigen and specific antibody. |
| Q47929303 | Preliminary Studies on the Cell-Mediated Immune Response in Pigs to Mycoplasma Hyopneumoniae |
| Q55455212 | Rheumatoid arthritis. Surgical treatment |
| Q39578048 | Rheumatoid arthritis: Review of searches for an infectious cause. Part II |
| Q36519534 | Rheumatoid disease, laboratory data |
| Q33568815 | Search for mycoplasma in synovial fluids from patients with rheumatoid arthritis |
| Q69563760 | Search for mycoplasma in synovial fluids from patients with rheumatoid arthritis |
| Q47859069 | Serum factor protecting against experimental arthritis. |
| Q74012738 | Structure of a novel phosphocholine-containing aminoglycoglycerolipid of Mycoplasma fermentans |
| Q69547502 | Studies on the infectious etiology of rheumatoid arthritis |
| Q69959475 | Tetracycline in the treatment of rheumatoid arthritis. A double blind controlled study |
| Q34074938 | Tetracyclines for the treatment of rheumatoid arthritis |
| Q43581456 | The effect of IgG in vitro on leukocytes from patients with rheumatoid arthritis |
| Q40097612 | The importance of B-cells and ecto-5'nucleotidase in Mycoplasma fermentans infection and the relevance to rheumatoid arthritis |
| Q30655354 | The physico-chemical characteristics of the phosphocholine-containing glycoglycerolipid MfGL-II govern the permeability properties of Mycoplasma fermentans |
| Q53648846 | The presence of bacteria in the synovial fluid of the temporomandibular joint and clinical significance: preliminary study |
| Q48197236 | The role of brain cytokines in mediating the behavioral and neuroendocrine effects of intracerebral mycoplasma fermentans. |
| Q45231221 | The role of the lymphocyte and its products in the propagation of joint disease |
| Q39510942 | Transcriptional activation of mRNA of intercellular adhesion molecule 1 and induction of its cell surface expression in normal human gingival fibroblasts by Mycoplasma salivarium and Mycoplasma fermentans |
| Q33568913 | Virus resistance transferred from human rheumatoid cells to rabbit synovial cells. I. Methods and results of intra-articular injection of human cells into rabbit joints |
| Q93705588 | Y chromosome fluorescence in bloodstains |
| Q68639593 | [Hepatitis-associated antigen: clinical and immunological significance] |
Search more.